European Archives of Oto-Rhino-Laryngology

, Volume 272, Issue 10, pp 2953–2959 | Cite as

The prognostic value of immunohistochemical markers for oral tongue squamous cell carcinoma

  • Jeong Seok Hwa
  • Oh Jin Kwon
  • Jung Je Park
  • Seung Hoon Woo
  • Jin Pyeong Kim
  • Gyung Hyuck Ko
  • Ji Hyun Seo
  • Rock Bum Kim
Head and Neck

Abstract

The objective of the study was to examine the prognostic value of hypoxia-inducible factor-1α (HIF-1α), carbonic anhydrase-IX (CA-IX), cyclooxygenase-2 (COX-2), Ki-67, and erythropoietin receptor in patients with oral tongue squamous cell carcinoma. Immunohistochemical analysis of marker expression was performed on tissue samples from 25 patients with tongue squamous cell carcinoma. The Kaplan–Meier method, univariate and multivariate analyses, and the Cox proportional hazards model were used to examine associations between patient and tumor characteristics, and the immunohistochemical results and disease-specific survival. There was no association between the expression of the five markers and disease-specific survival, and there was no statistically significant difference in the hazards ratio according to postoperative radiotherapy. There was no correlation between marker expression and prognosis. There was no association between marker expression and radioresistance or disease-specific survival. Therefore, HIF-1α, CA-IX, COX-2, Ki-67, and erythropoietin receptor are not suitable prognostic markers for tongue squamous cell carcinoma.

Keywords

Tongue Squamous cell carcinoma Prognosis Hypoxia-inducible factor-1α Carbonic anhydrase-IX 

References

  1. 1.
    Schrijvers ML, van der Laan BF, de Bock GH, Pattje WJ, Mastik MF, Menkema L, Langendijk JA, Kluin PM, Schuuring E, van der Wal JE (2008) Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1–T2 glottic laryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 72:161–169CrossRefPubMedGoogle Scholar
  2. 2.
    Moeller BJ, Richardson RA, Dewhirst MW (2007) Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 26:241–248CrossRefPubMedGoogle Scholar
  3. 3.
    Vordermark D, Brown JM (2003) Endogenous markers of tumor hypoxia predictors of clinical radiation resistance? Strahlenther Onkol 179:801–811CrossRefPubMedGoogle Scholar
  4. 4.
    Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309–316CrossRefPubMedGoogle Scholar
  5. 5.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2008) Estimates of worldwide burden of cancer in: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRefGoogle Scholar
  6. 6.
    Suslu N, Hosal AS, Aslan T, Sozeri B, Dolgun A (2013) Carcinoma of the oral tongue: a case series analysis of prognostic factors and surgical outcomes. J Oral Maxillofac Surg 71:1283–1290CrossRefPubMedGoogle Scholar
  7. 7.
    Gueiros LA, Coletta RD, Kowalski LP, Lopes MA (2011) Clinicopathological features and proliferation markers in tongue squamous cell carcinomas. Int J Oral Maxillofac Surg 40:510–515CrossRefPubMedGoogle Scholar
  8. 8.
    Bettendorf O, Piffko J, Bankfalvi A (2004) Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy? Oral Oncol 40:110–119CrossRefPubMedGoogle Scholar
  9. 9.
    Liang X, Zheng M, Jiang J, Zhu G, Yang J, Tang Y (2011) Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma. Oral Oncol 47:92–97CrossRefPubMedGoogle Scholar
  10. 10.
    Dunkel J, Vaittinen S, Grenman R, Kinnunen I, Irjala H (2013) Prognostic markers in stage I oral cavity squamous cell carcinoma. Laryngoscope 123:2435–2441PubMedGoogle Scholar
  11. 11.
    Kim SJ, Shin HJ, Jung KY, Baek SK, Shin BK, Choi J, Kim BS, Shin SW, Kim YH, Kim JS, Oosterwijk E (2007) Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue. Jpn J Clin Oncol 37:812–819CrossRefPubMedGoogle Scholar
  12. 12.
    Li HG, Li JS, Chen WL, Wang L, Wu DH, Lin ZY (2009) Prognostic significance of erythropoietin and erythropoietin receptor in tongue squamous cell carcinoma. Br J Oral Maxillofac Surg 47:470–475CrossRefPubMedGoogle Scholar
  13. 13.
    Wang YH, Wu MW, Yang AK, Zhang WD, Sun J, Liu TR, Chen YF (2011) COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway. Med Oncol 28(Suppl 1):S360–S366CrossRefPubMedGoogle Scholar
  14. 14.
    Sittel C, Ruiz S, Volling P, Kvasnicka HM, Jungehulsing M, Eckel HE (1999) Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity. Oral Oncol 35:583–589CrossRefPubMedGoogle Scholar
  15. 15.
    Jonathan RA, Wijffels KI, Peeters W, de Wilde PC, Marres HA, Merkx MA, Oosterwijk E, van der Kogel AJ, Kaanders JH (2006) The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Radiother Oncol 79:288–297CrossRefPubMedGoogle Scholar
  16. 16.
    Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225–239CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Jeong Seok Hwa
    • 1
  • Oh Jin Kwon
    • 1
  • Jung Je Park
    • 1
  • Seung Hoon Woo
    • 1
  • Jin Pyeong Kim
    • 1
  • Gyung Hyuck Ko
    • 2
  • Ji Hyun Seo
    • 2
  • Rock Bum Kim
    • 3
  1. 1.Department of Otolaryngology-Head and Neck Surgery and Urology, School of MedicineGyeongsang National UniversityJinjuSouth Korea
  2. 2.Department of Pathology and PediatricsGyeongsang National UniversityJinjuKorea
  3. 3.Dong-A University Hospital Regional Cardiocerebrovascular CenterBusanKorea

Personalised recommendations